Omentin, fat and heart: Classical music with new instruments

Heart Lung and Circulation

Volumn 23, Issue 9, 2014, Pages 802-806

  Katsi, Vasiliki ^a   Vamvakou, Georgia ^b   Lekakis, John ^b   Tousoulis, Dimitris ^a   Stefanadis, Christodoulos ^a   Makris, Thomas ^c   Kallikazaros, Ioannis ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c Helena Venizelou Maternity and General Hospital Cardiology Department   (Greece)

Author keywords

Cardiovascular effects; Inflammation; Insulin resistance; Novel adipokines; Obesity; Omentin

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; OMENTIN 1; OMENTIN 2; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASPIN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; OMENTIN PROTEIN, RAT;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTERY ENDOTHELIUM; ASTHMA; BODY FAT DISTRIBUTION; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; COLON CANCER; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MARKER; END STAGE RENAL DISEASE; GENE OVEREXPRESSION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPODYSTROPHY; LIVER CELL CARCINOMA; METABOLIC SYNDROME X; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OMENTUM; OSTEOARTHRITIS; OVARY CARCINOMA; OVARY POLYCYSTIC DISEASE; PARACRINE SIGNALING; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STOMACH CANCER; STRUCTURE ANALYSIS; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; WHITE ADIPOCYTE; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; DIABETES MELLITUS; ENDOTHELIUM; SECRETION (PROCESS);

ADIPOKINES; ADIPOSE TISSUE, WHITE; ANIMALS; CORONARY ARTERY DISEASE; CYTOKINES; DIABETES MELLITUS; ENDOTHELIUM; GPI-LINKED PROTEINS; HUMANS; INSULIN RESISTANCE; LECTINS; METABOLIC SYNDROME X; OBESITY;

EID: 84923818811     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.03.013     Document Type: Review

References (48)

1. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
2. Britton K.A., Fox C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011, 124:e837-e841.
3. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011, 11:85-97.
4. Schäfer K., Konstantinides S.V. Update on the cardiovascular risk in obesity: endocrine and paracrine role of the adipose tissue. Hellenic J Cardiol. 2011, 52(4):327-336.
5. De Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56:1655-1661.
6. Yamawaki H. Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses. Biol Pharm Bull 2011, 34:307-310.
7. Shibata R., Ouchi N., Kikuchi R., Takahashi R., Takeshita K., Kataoka Y., et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011, 219:811-814.
8. Giordano A, Smorlesi A, Frontini A, Barbatelli G, Cinti S. White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol. 2014 (in press).
9. Vosselman MJ, van Marken Lichtenbelt WD, Schrauwen P. Energy dissipation in brown adipose tissue: From mice to men. Mol Cell Endocrinol. 2013: S0303-7207(13): 00162-7.
10. Lo K.A., Sun L. Turning WAT into BAT: a review on regulators controlling the browning of white adipocytes. Biosci Rep. 2013, 33(5):711-719.
11. Bonet M.L., Oliver P., Palou A. Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta. 2013, 1831(5):969-985.
12. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395(6704):763-770.
13. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., et al. Leptin regulates proinflammatory immune responses. FASEB J 1998, 12(1):57-65.
14. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148(10):4687-4694.
15. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007, 282(38):28175-28188.
16. Curat C.A., Wegner V., Sengenès C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49(4):744-747.
17. Kamin D., Hadigan C., Lehrke M., Mazza S., Lazar M.A., Grinspoon S. Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone. J Clin Endocrinol Metab 2005, 90:3423-3426.
18. Hida K., Wada J., Eguchi J., Mazza S., Lazar M.A., Grinspoon S. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 2005, 102(30):10610-10615.
19. Yamawaki H., Tsubaki N., Mukohda M., Okada M., Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun 2010, 393:668-672.
20. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006, 290:E1253-E1261.
21. Schäffler A., Neumeier M., Herfarth H., Fürst A., Schölmerich J., Büchler C. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta. 2005, 1732:96-102.
22. Suzuki Y.A., Shin K., Lönnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry. 2001, 40:15771-15779.
23. Komiya T., Tanigawa Y., Hirohashi S. Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun. 1998, 251:759-762.
24. Lee J.K., Schnee J., Pang M., Wolfert M., Baum L.G., Moremen K.W., et al. Human homologs of the Xenopus oocyte cortical granule lectin XL35. Glycobiology. 2001, 11:65-73.
25. Gerwick L. Gene transcript changes in individual rainbow trout livers following an inflammatory stimulus. Fish Shellfish Immunol 2007, 22:157-171.
26. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004, 53(Suppl. 1):S143-S151.
27. Zheng L., Weng M., Qi M., Qi T., Tong L., Hou X., et al. Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis. J Cancer Res Clin Oncol 2012, 138:163-172.
28. Xu L., Zhu G.B., Wang L., Wang D.F., Jiang X.R. Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 2012, 60(3):583-586.
29. Kuperman D.A., Lewis C.C., Woodruff P.G., Rodriguez M.W., Yang Y.H., Dolganov G.M., et al. Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 2005, 116(2):305-311.
30. Xue Y., Jiang L., Cheng Q., Chen H., Yu Y., Lin Y., et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One 2012, 7(10):e46740.
31. Yilmaz Y., Yonal O., Kurt R. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven non alcoholic fatty liver disease. Scand J Gastrenterology 2011, 46:91-97.
32. Alcelik A., Tosun M., Ozlu M.F., Eroglu M., Aktas G., Kemahli E., et al. Serum levels of omentin in end-stage renal disease patients. Kidney Blood Press Res 2012, 35(6):511-516.
33. Barker G., Lim R., Georgiou H.M., Lappas M. Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One. 2012, 7(8):e42943.
34. Tan B., Adya R., Randeva S. Omentin: A novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 2010, 20:143-148.
35. Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. Journal of Obesity 2013; article ID 393192: 8 pages.
36. Cai R.C., Wei L., Di J.Z., Yu H.Y., Bao Y.Q., Jia W.P. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009, 89:381-384.
37. Pan H.Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010, 88:29-33.
38. Yoo H.J., Hwang S.Y., Hong H.C., Choi H.Y., Yang S.J., Seo J.A., et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol 2011, 10:103.
39. Tan B.K., Adya R., Farhacullah S., Lewandowski K.C., O'Hare P., Lehnert H., et al. Omentin-1, a novel adipokine, is decreased in overweight insulin resistant women with the polycystic ovary syndrome: Ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008, 57:801-808.
40. Wang Q., Feng X., Zhou Ch., Li P., Kang J. Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome. Ann Clin Biochem 2013, 50(Pt 3):230-235.
41. Calvin A.D., Albuquerque F.N., Lopez-Jimenez F., Somers V.K. Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 2009, 7:271-278.
42. Zhong X., Li X., Liu F., Tan H., Shang D. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun. 2012, 425(2):401-406.
43. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators of inflammation 2010, 2010:535918.
44. Moreno-Navarrete J.M., Ortega F., Castro A., Sabater M., Ricart W., Fernández-Real J.M. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity. 2011, (8):1552-1559.
45. Zhong X., Zhang H.Y., Tan H., Zhou Y., Liu F.L., Chen F.Q., et al. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 2011, 32(7):873-878.
46. El-Mesallamy H.O., El-Derany M.O., Hamdy N.M. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 2011, 28(10):1194-1200.
47. Moreno-Navarrete J.M., Catalán V., Ortega F., Gómez-Ambrosi J., Ricart W., Frühbeck G., et al. Circulating omentin concentration increases after weightloss. Nutr Metab (Lond) 2010, 7:27.
48. Siejka A., Jankiewicz-Wika J., Kołomecki K., Cywiński J., Piestrzeniewicz K., Swietosławski J., et al. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. Cytokine 2013, 64(2):490-493.